We construct the supercurrent and a supersymmetric current which satisfies the Adler-Bardeen theorem in supersymmetric Yang-Miils theory coupled to non-self-interacting chiral matter. Using the formulatiori recently developed by Grisaru, Milewski, and Zanon, supersymmetry and gauge invariance are maintained with supersymmetric background-field theory and regularization by dimensional reduction. We verify the finiteness of the supercurrent to one loop, and the Adler-Bardeen theorem to two loops by explicit calculations in the minimal-subtraction scheme. We then demonstrate the subtraction-scheme independence of the one-loop Adler-Bardeen anomaly and prove the existence of a subtraction scheme in which the Adler-Bardeen theorem is satisfied to all orders in perturbation theory. Soon after, ones' "solved" the consistency problem in an apparently simple way which also provided an allorders derivation of the / 3 function. His arguments were the following. The component G of the anomaly superfield which contains the axial anomaly has the form If the AB theorem is assumed, the anomalous divergence of the axial-vector current is equal to its one-loop value:Since it is the first component of the supercurrent, the anomalous divergence of j: should also be related to the /3 function and the anomaly superfield component G by Given these assumptions, not only are Eq. (1.2), which represents the AB theorem, and Eq. (1.31, the supercurrent equation, consistent, but they can also be solved for the all-orders /3 function. Amazingly, this procedure gives the correct two-loop value for the /3 function in pure supersymmetric Yang-Mills theory. Jones and
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.